Literature DB >> 8905874

Uterine leiomyosarcoma with osteoclast-like giant cells: histopathological and cytological observations.

K Watanabe1, H Hiraki, M Ohishi, K Mashiko, H Saginoya, T Suzuki.   

Abstract

A 56 year old woman presented with abnormal uterine bleeding. Except for a myomatous uterus, no other abnormalities were noted on physical examination and in radiographic and serologic studies. The hysterectomy specimen revealed an 8 cm uterine fundic tumor composed of two histologically different patterns that merged with one another; one was a well differentiated leiomyosarcoma and the other a mixture of osteoclast-like giant cells (OGC) and plump spindle cells whose cell borders blended, resembling the histology of giant cell tumor of bone. Immunohistochemical studies showed positive staining for muscle actin, alpha-smooth muscle actin, and KP-1 (CD68) in both the spindle cells and OGC. The latter also stained for alpha-1-antitrypsin and alpha-1-antichymotrypsin. These findings suggested that OGC may be formed by the fusion of spindle cells of leiomyosarcoma and also express histiocytic markers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905874     DOI: 10.1111/j.1440-1827.1996.tb03668.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.

Authors:  Mika Terasaki; Yasuhiro Terasaki; Kyoko Wakamatsu; Naomi Kuwahara; Koichi Yoneyama; Rieko Kawase; Keisuke Kurose; Etsuko Toda; Yoko Endo; Shinobu Kunugi; Yusuke Kajimoto; Akira Shimizu
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

2.  Osteoclast-like cells in soft tissue leiomyosarcomas.

Authors:  C L M H Gibbons; S G Sun; M Vlychou; K Kliskey; Y S Lau; A Sabokbar; N A Athanasou
Journal:  Virchows Arch       Date:  2010-02-02       Impact factor: 4.064

Review 3.  Giant cell tumor of the uterus: case report and response to chemotherapy.

Authors:  Keith M Skubitz; J Carlos Manivel
Journal:  BMC Cancer       Date:  2007-03-14       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.